← Back to Clinical Trials
Recruiting NCT07690982

NCT07690982 Assessing Posture and ROM With PhysioMaster in Stroke Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07690982
Status Recruiting
Phase
Sponsor Istinye University
Condition Stroke
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2026-07-13
Primary Completion 2026-09-26

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 70 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2026-07-13 with a primary completion date of 2026-09-26.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The smartphone application named PhysioMaster is an easy-to-use, accessible, and freely available application. Although it has been used in several previous studies, no validity or reliability study has yet been conducted in patients with stroke. Therefore, the aim of this study is to investigate the validity and reliability of the PhysioMaster smartphone application in patients with stroke. Accordingly, our hypotheses are as follows: * H0: The PhysioMaster application is not a valid and reliable measurement tool for the assessment of posture and range of motion in patients with stroke. * H1: The PhysioMaster application is a valid and reliable measurement tool for the assessment of posture and range of motion in patients with stroke. Participants will not take any intervention. Participants will be evaluated in terms of posture and range of motion by using PhysioMaster, Universal Goniometer and PostureScreen Mobile. During the first-day assessment, physiotherapists A and B will complete both the PhysioMaster application assessments and all other evaluations on the same patient without seeing each other's assessment scores. In order to evaluate the test-retest reliability of the application, physiotherapist A will repeat the assessments on Physiomaster on the same patient after 3 days.

Eligibility Criteria

Inclusion Criteria: * Presence of hemiplegia caused solely by stroke * Being older than 40 years and younger than 70 years of age * At least 6 months have passed since the stroke * Ability to maintain independent standing for at least 1 minute * Being at stage 4 or higher according to the Brunnstrom stages of stroke recovery * Ability to understand and follow instructions * Voluntary agreement to participate in the study Exclusion Criteria: * Presence of any neurological diagnosis other than stroke * History of orthopedic surgery within the last 6 months * Presence of concomitant orthopedic trauma * Presence of spasticity graded 3 or higher according to the Modified Ashworth Scale (MAS)

Contact & Investigator

Central Contact

Çiçek Günday, Asst. Prof

✉ cicek.gunday@istinye.edu.tr

📞 +90 850 283 60 00

Principal Investigator

Esra Çoban

STUDY CHAIR

Istinye University

Frequently Asked Questions

Who can join the NCT07690982 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07690982 currently recruiting?

Yes, NCT07690982 is actively recruiting participants. Contact the research team at cicek.gunday@istinye.edu.tr for enrollment information.

Where is the NCT07690982 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07690982 clinical trial?

NCT07690982 is sponsored by Istinye University. The principal investigator is Esra Çoban at Istinye University. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology